Trial intelligence / Profile preview

High-Dose Chemotherapy and Stem Cell Transplant in Advanced Breast Cancer

NCT00004172Phase 2Completed

Sponsor
Northwestern University
Start
Oct 1999
Primary completion
Oct 2003
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of carboplatin, ifosfamide, thiotepa in breast cancer, sponsored by Northwestern University. Started Oct 1999; status: completed.

02

Drugs

carboplatinifosfamidethiotepa
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00004172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call